FDA Approval Summary: Crizotinib for the Treatment of...

The Oncologist 2014 / 10 Vol. 19; Iss. 10

FDA Approval Summary: Crizotinib for the Treatment of Metastatic Non-Small Cell Lung Cancer With Anaplastic Lymphoma Kinase Rearrangements

Kazandjian, D., Blumenthal, G. M., Chen, H.-Y., He, K., Patel, M., Justice, R., Keegan, P., Pazdur, R.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
19
Language:
english
Journal:
The Oncologist
DOI:
10.1634/theoncologist.2014-0241
Date:
October, 2014
File:
PDF, 1.61 MB
english, 2014
Conversion to is in progress
Conversion to is failed